Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.
Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
PETBOOK magazine on MSN
Vestibular syndrome in dogs – not a stroke, but similarly dangerous
The dog suddenly tilts its head, stumbles while walking, or seems disoriented. Some animals vomit, others lean against walls, ...
News Medical on MSN
CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich's ataxia
The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for ...
Walking might seem simple. But it’s not, explains epidemiologist Peggy Cawthon, science director of the California Pacific Medical Center Research Institute. It’s an amazingly complex behavior that ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results